Skip to content

Study to evaluate the effect of Saraswatarishta and Panchakarma therapies in children with Autism.

An experimental and open label clinical study to evaluate the efficacy of Saraswatarishta and Panchakarma modalities in the management of Autism among children w.s.r. to Unmada - NIL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100444
Enrollment
20
Registered
2026-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

RGGPG Ayurvedic College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children between age group of 3 to 12 years diagnosed with autism using Indian Scale for Assessment of Autism. Children without any acute illness or medical emergencies. Parents of study subjects willing to participate in the trial.

Exclusion criteria

Exclusion criteria: Children below 3 years of age and above 12 years of age. Children with severe comorbidities (Epilepsy or seizure disorders etc.) Children diagnosed with genetic conditions like Down syndrome, Rett syndrome or Fragile X syndrome. Parents of the children not willing to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Fulfillment of objective and subjective criteriaTimepoint: 90 Days

Secondary

MeasureTime frame
To evaluate the clinical safety and tolerability of Saraswatarishta and Panchakarma modalitiesTimepoint: 90 Days

Countries

India

Contacts

Public ContactDr Sakshi Thakur

RGGPG Ayurvedic College and Hospital

drminakshi2050@gmail.com9418017565

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026